Sean:
NP having never dipped his toe into biotech waters, nor been the CEO of anything, never managed people, having zero contacts in the industry was grossly ill fit for the position he bought. He was also previously charged/convicted of personal enrichment at shareholders expense and in my six years invested with company has run the O/S from 175 million to 900 million without a whiff of drug approval while simultaneously alienating the governing body that holds our fate in their hands.

While I agree that during his tenure the drug has teased/demonstrated hope and curative possibilities, the stench of his stewardship continues to harm and hamstring the company- Lalezari himself characterized the front office as the most incompetent he's witnessed in his long career and I'm excited that finally this potentially powerful drug will be guided by a competent experienced and mature team of people - NP can rot in prison for all I care- and this from a guy who actually made out pretty handsomely due to his carney pumping and illegal activities-